Truglif 25mg Tablet

Truglif 25mg Tablet contains the active ingredient Empagliflozin, which belongs to the class of sodium-glucose co-transporter 2 (SGLT2) inhibitors. Empagliflozin works by inhibiting the reabsorption of glucose in the kidneys, thereby promoting the excretion of excess glucose in the urine. This helps lower blood sugar levels and is prescribed for the treatment of type 2 diabetes mellitus.

Uses:

Truglif 25mg Tablet is primarily used for the management of type 2 diabetes mellitus. It helps improve glycemic control by reducing blood sugar levels in patients with diabetes. This medication is typically prescribed along with diet and exercise to achieve optimal control of blood glucose levels.

Benefits:

• Lowering blood glucose levels: Empagliflozin helps lower blood sugar levels by increasing the excretion of glucose in the urine, thereby reducing hyperglycemia in patients with type 2 diabetes mellitus.
• Cardiovascular benefits: In addition to its glucose-lowering effects, Empagliflozin has been shown to reduce the risk of cardiovascular events and improve cardiovascular outcomes in patients with diabetes and established cardiovascular disease.
• Renal benefits: Empagliflozin has also demonstrated renal protective effects, including reducing the risk of progression of kidney disease and delaying the onset of end-stage renal disease in patients with type 2 diabetes mellitus.

Dosage and Administration:

The recommended dosage of Truglif 25mg Tablet may vary depending on the individual patient’s condition and response to treatment. It is typically taken orally once daily, with or without food. It is important to follow the dosage instructions provided by the healthcare provider to achieve optimal glycemic control.

Precautions:

• Truglif 25mg Tablet should be used with caution in patients with renal impairment, as Empagliflozin is primarily excreted renally. Dose adjustments may be necessary based on renal function.
• Patients taking Truglif should be monitored regularly for signs of ketoacidosis, urinary tract infections, genital mycotic infections, hypoglycemia, and other adverse effects.
• It is important to review the patient’s medication history and monitor for potential drug interactions, especially with medications that affect renal function or glycosuria.

In Summary:

Truglif 25mg Tablet contains Empagliflozin, a medication used for the management of type 2 diabetes mellitus. By inhibiting glucose reabsorption in the kidneys, Empagliflozin helps lower blood sugar levels and offers additional cardiovascular and renal benefits in patients with diabetes.